SYNGENE INTERNATIO chart

Last update: 2022-06-03
Key statistics and financials
Revenue per share 65.40
Dividend & Yield0.50₹ (0.09%)
Beta 0.68
Market capitalization 224.68B
Operating cash flow 5.81B
ESG Scores unknown

Company description

Syngene International Limited, a contract research and manufacturing company, provides drug discovery and development services in India, the United States, and internationally. The company offers discovery chemistry services, such as medicinal and synthetic chemistry, library and peptide synthesis, biomolecules, organic electronic materials, and computational and analytical chemistry; and discovery biology services in the areas of recombinant DNA engineering, cell line development, hybridoma technology, sequencing, protein sciences, screening and assay biology, DMPK, in vivo pharmacology, toxicology, and biologicals. It also provides exploratory/discovery, in vitro and genetic, and developmental and reproductive toxicology services, as well as acute, sub-chronic, and chronic toxicity studies; and chemical, formulation, analytical, and clinical development services, as well as commercial manufacturing services. In addition, the company offers lead generation, preclinical development, API, and drug product development services; and clinical trial management, pharmacokinetic analysis/bioanalytical, central lab, biometrics and clinical data management, regulatory, medical monitoring, pharmacovigilance, and medical writing services. Further, it provides other drug modalities, which include peptides, oligonucleotide synthesis, antibody drug conjugate, PROTACs, and CAR T-cell therapy services. The company serves pharmaceutical, biotechnology, nutrition, animal health, consumer goods, specialty chemical, and other companies. It has partnerships and collaborations with Bristol-Myers Squibb Co.; Baxter International Inc.; Amgen Inc.; PharmAust Limited; and HiMedia Laboratories. The company was incorporated in 1993 and is headquartered in Bengaluru, India. Syngene International Limited is a subsidiary of Biocon Limited.

Sector: Healthcare - Industry: Biotechnology

Financial Ratios
Quick Ratio1.65
Working Capital0.41
Return On Equity0.12
Debt To Equity0.16
Fixed Asset Ratio0
Fixed Interest Cover17.91

Financial data

Financial Statements

Cashflow Statement 2019-03-31 2020-03-31 2021-03-31 2022-03-31
Change To Liabilities 2.23B 2.36B -51M 546M
Total Cashflows From Investing Activities -6.46B -4.28B -6.28B -6.12B
Net Borrowings -203M -1.66B 849M -138M
Total Cash From Financing Activities -724M -2.25B 580M -313M
Change To Operating Activities -126M -1.74B 381M -783M
Issuance Of Stock 19M 7M 8M
Net Income 3.32B 4.12B 4.05B 3.96B
Change In Cash -875M 278M 1.3B -615M
Effect Of Exchange Rate 10M 46M -8M 7M
Total Cash From Operating Activities 6.3B 6.77B 7.01B 5.81B
Depreciation 1.61B 2.15B 2.7B 3.1B
Change To Account Receivables -704M -362M 381M -362M
Other Cashflows From Financing Activities -299M -358M -277M -175M
Change To Netincome -475M 16M -149M 548M
Capital Expenditures -5.82B -6.3B -4.41B -4.75B

Income Statement 2019-03-31 2020-03-31 2021-03-31 2022-03-31
Research Development
Income Before Tax 4.15B 5.17B 4.69B 4.84B
Net Income 3.32B 4.12B 4.05B 3.96B
Selling General Administrative 5.02B 6B 6.78B 7.18B
Gross Profit 12.09B 13.89B 15.28B 18.55B
Ebit 3.75B 3.84B 3.86B 4.32B
Operating Income 3.75B 3.84B 3.86B 4.32B
Interest Expense -323M -346M -277M -241M
Income Tax Expense 838M 1.05B 643M 886M
Total Revenue 18.26B 20.12B 21.84B 26.04B
Cost Of Revenue 6.17B 6.23B 6.57B 7.49B
Total Other Income ExpenseNet 409M 1.33B 831M 528M
Net Income From Continuing Ops 3.32B 4.12B 4.05B 3.96B
Net Income Applicable To Common Shares 3.32B 4.12B 4.05B 3.96B

Balance Sheet Statement 2019-03-31 2020-03-31 2021-03-31 2022-03-31
Total Liabilities 17.35B 19.87B 20.62B 22.66B
Total Stockholder Equity 19.68B 21.76B 28.21B 32.98B
Other Current Liabilities 4.13B 5.69B 5.52B 6.58B
Total Assets 37.03B 41.63B 48.83B 55.64B
Common Stock 2B 4B 4B 4.01B
Other Current Assets 738M 369M 1.03B 2.37B
Retained Earnings 15.96B 17.78B 21.82B
Treasury Stock 450M -1.35B 944M 28.97B
Cash 1.65B 1.93B 3.23B 5.18B
Total Current Liabilities 11.29B 15.39B 11.33B 12.29B
Other Stockholder Equity 496M -1.31B 976M 28.97B
Property, Plant, and Equipment 15.96B 21.97B 23.82B 26.88B
Total Current Assets 17.64B 16.13B 18.07B 22.06B
Net Tangible Assets 19.54B 21.55B 28.02B 32.85B
Net Receivables 4.73B 5.1B 5.54B 5.08B
Accounts Payable 2.23B 2.22B 2.42B 2.33B


Insider Transactions

Here are the insider transactions of stock shares related to SYNGENE INTERNATIO:

Filer Name Transaction Text Ownership Date Filer Relation Shares
Tamhankar (Chetan prakash)Other at price 8.13 per share.D2022-05-04UNREPORTED2.76k
Biocon India Ltd Employee Welfare TrustOther at price 7.84 per share.D2022-03-31Promoter12.44k
Chakrabarti (Anjan)Other at price 7.77 per share.D2022-03-30UNREPORTED5k
Chakrabarti (Anjan)Other at price 7.89 per share.D2022-03-23UNREPORTED2.5k
Manocha (Ajit)Other at price 7.70 per share.D2022-03-22UNREPORTED13.36k
Pandey (Mohan)Other at price 6.97 per share.D2022-03-08UNREPORTED20.6k
Pandey (Mohan)Other at price 6.94 per share.D2022-03-08UNREPORTED20.6k
Biocon India Ltd Employee Welfare Trust LtdSale at price 7.32 per share.D2022-02-23Promoter4.23k
Chakrabarti (Anjan)Other at price 7.76 per share.D2022-02-01UNREPORTED2.5k
Rao (Ranga JVSMK)Other at price 8.10 per share.D2021-12-28UNREPORTED1k
Rao (Ranga JVSMK)Other at price 8.03 per share.D2021-12-24UNREPORTED1k
Bhalgat (Mahesh K)Other at price 8.13 per share.D2021-12-23UNREPORTED47.5k
Biocon India Ltd Employee Welfare Trust LtdSale at price 4.90 per share.D2021-12-23Promoter12k
Biswas (Sibaji)Other at price 8.13 per share.D2021-12-23UNREPORTED41.5k
Hunt (Jonathan Brittan)Other at price 7.88 per share.D2021-12-03UNREPORTED24.6k
Hunt (Jonathan Brittan)Other at price 7.83 per share.D2021-12-03UNREPORTED24.6k
Chakrabarti (Anjan)Other at price 7.99 per share.D2021-11-30UNREPORTED5k
Aiyar (Jayashree)Other at price 7.81 per share.D2021-11-24UNREPORTED7.64k
Eswarnath (H K)Other at price 7.81 per share.D2021-11-24UNREPORTED2.48k
Kumar (K A Yeshwanth)Other at price 7.81 per share.D2021-11-24UNREPORTED4.88k
Kumar (Nanda K)Other at price 7.81 per share.D2021-11-24UNREPORTED39.6k
Singnurkar (Purushottam)Other at price 7.81 per share.D2021-11-24UNREPORTED19.21k
Tamhankar (Chetan prakash)Other at price 7.81 per share.D2021-11-24UNREPORTED5.19k
Chakrabarti (Anjan)Sale at price 8.26 per share.D2021-11-22UNREPORTED4.33k
Bhalgat (Mahesh K)Other at price 8.18 per share.D2021-11-18UNREPORTED40k
Bhalgat (Mahesh K)Other at price 8.18 per share.D2021-11-18UNREPORTED40k
Biswas (Sibaji)Other at price 8.18 per share.D2021-11-18UNREPORTED35.5k
Biswas (Sibaji)Other at price 8.18 per share.D2021-11-18UNREPORTED35.5k
Biocon India Ltd Employee Welfare Trust LtdSale at price 7.42 per share.D2021-11-12Promoter21.43k
Chakrabarti (Anjan)Other at price 7.33 per share.D2021-11-12UNREPORTED30.73k
Chakrabarti (Anjan)Sale at price 7.47 per share.D2021-11-12UNREPORTED11.4k
Kamath (Mukesh)Purchase at price 8.00 per share.D2021-11-12UNREPORTED6.63k
Biocon India Ltd Employee Welfare Trust LtdOther at price 8.64 per share.D2021-09-27Promoter5.64k
Mohan (K)Sale at price 8.63 per share.D2021-09-27UNREPORTED8.04k
Mohan (K)Sale at price 8.86 per share.D2021-09-24UNREPORTED3.97k
Aravindan (Raghavan)Other at price 8.97 per share.D2021-09-24UNREPORTED11.52k
Aravindan (Raghavan)Sale at price 8.75 per share.D2021-09-24UNREPORTED4.3k
Mohan (K)Other at price 8.71 per share.D2021-09-21UNREPORTED19.21k
Mohan (K)Sale at price 8.90 per share.D2021-09-21UNREPORTED7.2k
Rao (Ranga JVSMK)Sale at price 8.72 per share.D2021-09-20UNREPORTED4.8k
Rao (Ranga JVSMK)Other at price 8.89 per share.D2021-09-17UNREPORTED19.21k
Chakraborthy (Manideepa)Other at price 8.89 per share.D2021-09-17UNREPORTED2.4k
Poojary (Ananda)Other at price 9.09 per share.D2021-09-16UNREPORTED11.42k
Poojary (Ananda)Sale at price 8.97 per share.D2021-09-16UNREPORTED4.3k
Mittal (Siddharth)Sale at price 9.19 per share.D2021-09-15UNREPORTED46.23k
Patil (Rajendra Dhruva)Sale at price 8.83 per share.D2021-09-13UNREPORTED4.9k
Tamhankar (Chetan prakash)Sale at price 8.57 per share.D2021-09-13UNREPORTED7k
Patil (Rajendra Dhruva)Sale at price 8.50 per share.D2021-09-09UNREPORTED8.7k
Patil (Rajendra Dhruva)Sale at price 8.68 per share.D2021-09-02UNREPORTED8.6k
Patil (Rajendra Dhruva)Other at price 8.72 per share.D2021-09-02UNREPORTED8.6k
Mehrotra (Alok)Sale at price 8.59 per share.D2021-08-30UNREPORTED12.5k

Insider transaction explanations

Insider buying is the legal purchase of shares by a senior executive or director of a company. "Filer Name" corresponds to the name of the stock buyer or seller. "Transaction Text" describes the transaction. "Ownership" gives information about the transaction type. "Date" is the reported transaction date. "Filer Relation" gives the role of the insider in the company. "Shares" is the value of the transaction. You will find the complete description of the General Transaction Codes on the SEC dedicated page


Investment strategy backtesting

These are the result of three automatic investment systems applied to SYNGENE INTERNATIO. You will find the performance of an systematic investment system, a momentum strategy, and a buy the dip trading strategy.


Systematic investment results on SYNGENE INTERNATIO

Here is the result of two systematic investment strategies applied to SYNGENE INTERNATIO. The first strategy automatically buys the first day of the month, and the second strategy buys the fifteenth day of the month.

Systematic investment equity curve on SYNGENE INTERNATIO

The following chart shows the equity curve of the two systematic investment strategies applied to SYNGENE INTERNATIO:

SYNGENE INTERNATIO automated entries

The systematic investment strategy that buys the first day of the month would give a performance of 30.65% on the backtest period.

Performance at glance

Performance

30.65 %

Latent gain

1312.52 ₹

Invested capital

4282.48 ₹

Annualized return

7.26 %
Build your Trading System
Automated Trading using Prorealtime ebook

Momentum strategy results on SYNGENE INTERNATIO

This is the result of two momentum investment strategies applied to SYNGENE INTERNATIO. The first strategy uses a momentum signal calculated on one quarter, and the second uses a momentum signal calculated on two quarters.

Momentum entry openings on SYNGENE INTERNATIO

The following chart shows all the entries opened by the momentum investment system on SYNGENE INTERNATIO:

SYNGENE INTERNATIO momentum entries
  • The first momentum investment strategy would give 34.83% of return on SYNGENE INTERNATIO. That represents 3468.7₹ of latent gain with 9959.3₹ of employed capital.
  • The second momentum investment strategy would give 33.12% of return on SYNGENE INTERNATIO. That represents 2088.1₹ of latent gain with 6304.4₹ of employed capital.
Performance at glance (1Q Momentum)

Performance

34.83 %

Latent gain

3468.7 ₹

Invested capital

9959.3 ₹

Annualized return

-0.55 %
Performance at glance (2Q Momentum)

Performance

33.12 %

Latent gain

2088.1 ₹

Invested capital

6304.4 ₹

Annualized return

8.86 %

Momentum equity curve on SYNGENE INTERNATIO

The following chart shows the equity curve of the two momentum strategies applied to SYNGENE INTERNATIO:

SYNGENE INTERNATIO momentum equity

Note: the dividends potentially given by SYNGENE INTERNATIO are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on SYNGENE INTERNATIO

The following chart shows the employed capital evolution of the two momentum strategies on SYNGENE INTERNATIO since the beginning:

SYNGENE INTERNATIO

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250₹, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000₹.


Buy the dip strategy result on SYNGENE INTERNATIO

Buy the dip entry openings on SYNGENE INTERNATIO

SYNGENE INTERNATIO

The performance achieved by the robo-advisor on SYNGENE INTERNATIO is -1.22%. That represents -6.9$ of latent gain with 566.4₹ of employed capital. The following chart shows SYNGENE INTERNATIO stock price with all the entries opened by the automated investment system.

Note: The blue line represents the weekly stock price of SYNGENE INTERNATIO, and the green triangles represent the entry openings. The artificall robo-advisor needs at least 100 weeks of trading history to work.

Performance at glance

Performance

-1.22 %

Latent gain

-6.9 ₹

Invested capital

566.4 ₹

Annualized return

-0.55 %

Equity curve of the strategy applied to SYNGENE INTERNATIO

The following chart shows the result of the investment strategy applied to SYNGENE INTERNATIO:

SYNGENE INTERNATIO

Note: the dividends potentially given by SYNGENE INTERNATIO are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on SYNGENE INTERNATIO

The following chart shows the employed capital evolution since the beginning of the investment strategy on SYNGENE INTERNATIO:

SYNGENE INTERNATIO

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250$, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000$.


Investment strategies comparison on SYNGENE INTERNATIO

In this section, I will compare the three previous investment strategies applied to SYNGENE INTERNATIO.

Equity curve comparison on SYNGENE INTERNATIO

The following chart shows the equity curve of the artificall advisor, the trend folowing and the automatic investment strategies:

SYNGENE INTERNATIO investment strategy comparison

Employed capital comparison on SYNGENE INTERNATIO

SYNGENE INTERNATIO investment comparison

Performance comparison on SYNGENE INTERNATIO

Strategy Latent Profit Growth Employed capital CAGR
Automatic investment 30.65% 1312.52₹ 4282.48₹ 7.26%
Momentum 1 quarter 34.83% 3468.7₹ 9959.3₹ 8.75%
Momentum 2 quarters 33.12% 2088.1₹ 6304.4₹ 8.86%
Non-directional -1.22% -6.9₹ 566.4₹ -0.55%
Annualized return comparison

Automatic investment

7.26 %

Momentum 1Q

8.86 %

Momentum 2Q

8.86 %

Non-directional

-0.55 %

Correlated stocks

Here are the most positively and negatively correlated stocks with SYNGENE INTERNATIO:

Positive correlations

Most correlated stocks this year


Most correlated stocks last 3 months

Negative correlation

Most negatively correlated stocks this year


Most negatively correlated stocks last 3 months

Note: The algorithm computes the probability of correlation between SYNGENE INTERNATIO and the other stocks. There may be false positives or some missing correlated stocks. If the price of SYNGENE INTERNATIO does not vary for 36 weeks, the correlation calculation result will be wrong.


Company information

Company name SYNGENE INTERNATIO
Country India
City Bengaluru
Address Biocon SEZ, Biocon Park,
Phone 91 80 6891 8000
Website www.syngeneintl.com
FullTime employees
Industry Biotechnology
Sector Healthcare
Exchange XNSE
Ticker SYNGENE.XNSE
Market

SYNGENE INTERNATIO ESG Scores

Environment scores

Environment ESG Factors Scores
Environment Score 0
Peer Environment Performance unknown
Environment Percentile unknown
Palm Oil unknown
Nuclear unknown
Fur Leather unknown
GMO unknown
Coal unknown
Pesticides unknown
Animal Testing unknown

Social scores

Social ESG Factors Scores
Social Score 0
Peer Social Performance unknown
Social Percentile unknown
Highest Controversy unknown
Peer Highest Controversy Performance unknown
Adult unknown
Gambling unknown
Alcoholic unknown
Tobacco unknown
Catholic unknown
Controversial Weapons unknown
Small Arms unknown
Military Contract unknown
Peer Count unknown

Related Controversy:


Governance scores

Governance ESG Factors Scores
Governance Score 0
Peer Governance Performance unknown
Governance Percentile unknown

ESG at glance
Total ESG Scores: unknown
Environment Score: 0
Social Score: 0
Governance Score: 0

ESG Performance: unknown

Peer Group: unknown

Peer Esg Score Performance: unknown

Rating Year: unknown

Rating Month: unknown

Max Age: unknown

Percentile: unknown